Company news
Medipal Holdings Corporation (TSE:7459) news
Every Medipal Holdings Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Notice Regarding Changes of Representative Directors and Directors
September 8, 2026
Silchester International Investors - Press Release and EGM Demand Letter - Medipal Holdings Corporation (7459:JT)
September 2, 2026
Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2027
August 5, 2026
Notice Regarding Revision of Full-Year Consolidated Financial Forecasts
July 14, 2026
Notice Regarding Results of the Tender Offer for Shares of PALTAC CORPORATION (Securities Code: 8283)
July 8, 2026
MediPal : Consolidated Financial Statements for the Fiscal Year Ended March 31, 2026
May 14, 2026
MediPal : Notice Regarding Dividends of Retained Earnings (Dividend Increase)
May 14, 2026
MediPal : Notice of Investment in Metagen Therapeutics, Inc. through MEDIPAL Innovation Fund
February 25, 2026
MediPal : (Update on Disclosed Matter) Notice Regarding the Completion of MP AGRO CO., LTD.'s Acquisition of Cygni Holdings, Inc. Shares
January 30, 2026
MediPal : Notice Regarding Results and Completion of Acquisition of Treasury Stock and Number of Cancellation Shares of Treasury Stock
November 5, 2025
MediPal : Notice Regarding Business Transfer of Consolidated Subsidiary
October 28, 2025
MediPal : Notice Regarding MP AGRO CO., LTD.'s Acquisition of All Shares of Cygni Holdings, Inc.
October 9, 2025
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by Ministry of Health, Labour and Welfare of Japan
September 29, 2025
MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis
September 2, 2025
MediPal : Notice Regarding Progress of Acquisition of Treasury Stock
August 4, 2025
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by European Commission (EC)
June 24, 2025
MediPal : Notice of Acquisition of Shares of PHARUMO, Inc.
June 10, 2025
MediPal : Notice of Completion of MEDICEO “Medical Distribution Center Kobe”
May 27, 2025
MediPal : Notice of Transfer of Representative Director (Additional Selection) and Acting President
May 23, 2025
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by the U.S. FDA
May 7, 2025